观点网讯:6月13日,药捷安康-B(02617)宣布全球发售计划。本次全球发售涉及15,281,000股H股,其中香港发售股份数目为1,528,500股H股,国际发售股份数目为13,752,500股H股。发售价定为每股H股13.15港元。股份代号为2617,每股H股面值为人民币1.00元。此次发售涉及多个角色,包括联席保荐人、整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人,但具体名称未...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.